In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Fradiomycin Sulfate Drug Master File in Korea (Fradiomycin Sulfate KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Fradiomycin Sulfate. The MFDS reviews the Fradiomycin Sulfate KDMF as part of the drug registration process and uses the information provided in the Fradiomycin Sulfate KDMF to evaluate the safety and efficacy of the drug.
After submitting a Fradiomycin Sulfate KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Fradiomycin Sulfate API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Fradiomycin Sulfate suppliers with KDMF on PharmaCompass.